Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,266 | -17,211 | -8,461 | -11,764 | -9,477 |
| Depreciation Amortization | 697 | 488 | 300 | 192 | 113 |
| Accounts receivable | -642 | -1,848 | -649 | -890 | 132 |
| Other Working Capital | -1,452 | -938 | -852 | 1,229 | -452 |
| Other Operating Activity | 3,905 | 8,670 | 3,201 | 4,501 | 637 |
| Operating Cash Flow | $-16,759 | $-10,840 | $-6,461 | $-6,731 | $-9,048 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 2,192 | -248 |
| PPE Investments | -698 | -672 | -991 | -141 | -404 |
| Purchase Sale Intangibles | -822 | -848 | -687 | -455 | -240 |
| Other Investing Activity | -822 | -848 | -687 | -455 | -240 |
| Investing Cash Flow | $-1,520 | $-1,520 | $-1,678 | $1,597 | $-891 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 667 | 5,000 | 5,000 | N/A |
| Debt Repayment | 0 | -667 | 0 | N/A | N/A |
| Common Stock Issued | 2,508 | 3,487 | 1,445 | 183 | 2,116 |
| Other Financing Activity | 670 | 13,979 | 13,678 | -119 | 9,524 |
| Financing Cash Flow | $8,178 | $17,466 | $20,123 | $5,064 | $11,640 |
| Exchange Rate Effect | -35 | -59 | 92 | -1 | 10 |
| Beginning Cash Position | 22,369 | 17,322 | 5,245 | 5,317 | 3,605 |
| End Cash Position | 12,232 | 22,369 | 17,322 | 5,245 | 5,317 |
| Net Cash Flow | $-10,136 | $5,047 | $12,077 | $-72 | $1,712 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,759 | -10,840 | -6,461 | -6,731 | -9,048 |
| Capital Expenditure | -698 | -672 | -991 | -141 | -404 |
| Free Cash Flow | -17,457 | -11,512 | -7,451 | -6,872 | -9,451 |